Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer

Fig. 2

Distribution of the adjusted polygenic risk score according to the different 5 groups by fecal immunochemical test result. Only screening samples are represented in this figure. Data are represented as the mean and 95% CI for each risk group. Negative fecal immunochemical test defined as < 20 μg Hb/g feces. Positive fecal immunochemical test defined as ≥ 20 μg Hb/g feces

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us